Unknown

Dataset Information

0

Activation of guanylate cyclase-C attenuates stretch responses and sensitization of mouse colorectal afferents.


ABSTRACT: Irritable bowel syndrome (IBS) is characterized by altered bowel habits, persistent pain and discomfort, and typically colorectal hypersensitivity. Linaclotide, a peripherally restricted 14 aa peptide approved for the treatment of IBS with constipation, relieves constipation and reduces IBS-associated pain in these patients presumably by activation of guanylate cyclase-C (GC-C), which stimulates production and release of cyclic guanosine monophosphate (cGMP) from intestinal epithelial cells. We investigated whether activation of GC-C by the endogenous agonist uroguanylin or the primary downstream effector of that activation, cGMP, directly modulates responses and sensitization of mechanosensitive colorectal primary afferents. The distal 2 cm of mouse colorectum with attached pelvic nerve was harvested and pinned flat mucosal side up for in vitro single-fiber recordings, and the encoding properties of mechanosensitive afferents (serosal, mucosal, muscular, and muscular-mucosal; M/M) to probing and circumferential stretch studied. Both cGMP (10-300 μM) and uroguanylin (1-1000 nM) applied directly to colorectal receptive endings significantly reduced responses of muscular and M/M afferents to stretch; serosal and mucosal afferents were not affected. Sensitized responses (i.e., increased responses to stretch) of muscular and M/M afferents were reversed by cGMP, returning responses to stretch to control. Blocking the transport of cGMP from colorectal epithelia by probenecid, a mechanism validated by studies in cultured intestinal T84 cells, abolished the inhibitory effect of uroguanylin on M/M afferents. These results suggest that GC-C agonists like linaclotide alleviate colorectal pain and hypersensitivity by dampening stretch-sensitive afferent mechanosensitivity and normalizing afferent sensitization.

SUBMITTER: Feng B 

PROVIDER: S-EPMC3739058 | biostudies-other | 2013 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

Activation of guanylate cyclase-C attenuates stretch responses and sensitization of mouse colorectal afferents.

Feng Bin B   Kiyatkin Michael E ME   La Jun-Ho JH   Ge Pei P   Solinga Robert R   Silos-Santiago Inmaculada I   Gebhart Gerald F GF  

The Journal of neuroscience : the official journal of the Society for Neuroscience 20130601 23


Irritable bowel syndrome (IBS) is characterized by altered bowel habits, persistent pain and discomfort, and typically colorectal hypersensitivity. Linaclotide, a peripherally restricted 14 aa peptide approved for the treatment of IBS with constipation, relieves constipation and reduces IBS-associated pain in these patients presumably by activation of guanylate cyclase-C (GC-C), which stimulates production and release of cyclic guanosine monophosphate (cGMP) from intestinal epithelial cells. We  ...[more]

Similar Datasets

| S-EPMC6919197 | biostudies-literature
| S-EPMC3047459 | biostudies-literature
| S-EPMC2916748 | biostudies-literature
| S-EPMC8196705 | biostudies-literature
| S-EPMC3827477 | biostudies-literature
| S-EPMC3588102 | biostudies-literature
| S-EPMC8448884 | biostudies-literature
| S-EPMC2850410 | biostudies-literature
| S-EPMC2791033 | biostudies-literature
| S-EPMC5742255 | biostudies-literature